{
    "id": 26607,
    "fullName": "IGFBP2 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "IGFBP2 positive indicates the presence of the IGFBP2 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3485,
        "geneSymbol": "IGFBP2",
        "terms": [
            "IGFBP2",
            "IBP2",
            "IGF-BP53"
        ]
    },
    "variant": "positive",
    "createDate": "05/23/2017",
    "updateDate": "02/04/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10970,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, ovarian cancer patients demonstrated increased levels of IGFBP2 specific T cells compared to baseline and an overall survival rate of 82% at two years when treated with IGFBP-2 vaccine (J Clin Oncol 34, 2016 (suppl; abstr 5542).",
            "molecularProfile": {
                "id": 27865,
                "profileName": "IGFBP2 positive"
            },
            "therapy": {
                "id": 5750,
                "therapyName": "IGFBP-2 vaccine",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8966,
                    "pubMedId": null,
                    "title": "Vaccination targeting insulin-like growth factor binding protein-2 (IGFBP-2) in advanced ovarian cancer: Safety and immunogenicity",
                    "url": "http://meetinglibrary.asco.org/content/165931-176"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27865,
            "profileName": "IGFBP2 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}